CATALOGO DEI PRODOTTI DELLA RICERCA

Zaza, Gianluigi
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 7.546
NA - Nord America 7.463
AS - Asia 5.091
SA - Sud America 760
AF - Africa 111
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 10
Totale 20.993
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.336
RU - Federazione Russa 2.814
SG - Singapore 1.989
CN - Cina 1.522
GB - Regno Unito 1.511
IT - Italia 867
BR - Brasile 587
SE - Svezia 556
FR - Francia 499
VN - Vietnam 471
HK - Hong Kong 400
DE - Germania 360
IE - Irlanda 352
FI - Finlandia 255
KR - Corea 175
IN - India 106
UA - Ucraina 80
AR - Argentina 71
ID - Indonesia 71
CA - Canada 60
BD - Bangladesh 46
TR - Turchia 45
AT - Austria 42
JP - Giappone 42
MX - Messico 40
PK - Pakistan 38
BE - Belgio 34
IQ - Iraq 34
ZA - Sudafrica 34
NL - Olanda 30
PL - Polonia 28
EC - Ecuador 26
ES - Italia 23
PH - Filippine 21
CO - Colombia 18
VE - Venezuela 18
MA - Marocco 14
NG - Nigeria 14
RO - Romania 14
UZ - Uzbekistan 13
CL - Cile 12
SA - Arabia Saudita 12
AU - Australia 11
CZ - Repubblica Ceca 11
IL - Israele 11
PY - Paraguay 11
CH - Svizzera 10
GR - Grecia 10
MY - Malesia 10
AZ - Azerbaigian 9
JO - Giordania 9
DZ - Algeria 8
AE - Emirati Arabi Uniti 7
DK - Danimarca 7
PE - Perù 7
EG - Egitto 6
GE - Georgia 6
KE - Kenya 6
KZ - Kazakistan 6
LB - Libano 6
PS - Palestinian Territory 6
BO - Bolivia 5
EU - Europa 5
LV - Lettonia 5
TN - Tunisia 5
XK - ???statistics.table.value.countryCode.XK??? 5
DO - Repubblica Dominicana 4
HR - Croazia 4
HU - Ungheria 4
LA - Repubblica Popolare Democratica del Laos 4
LT - Lituania 4
NP - Nepal 4
RS - Serbia 4
SV - El Salvador 4
TG - Togo 4
UY - Uruguay 4
AL - Albania 3
BG - Bulgaria 3
BH - Bahrain 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
ET - Etiopia 3
HN - Honduras 3
KG - Kirghizistan 3
NI - Nicaragua 3
NO - Norvegia 3
OM - Oman 3
SY - Repubblica araba siriana 3
BJ - Benin 2
CG - Congo 2
LK - Sri Lanka 2
ME - Montenegro 2
PA - Panama 2
PT - Portogallo 2
QA - Qatar 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AD - Andorra 1
Totale 20.961
Salva come PNG Salva come JPEG
Città #
Southend 1.312
Ashburn 1.184
Singapore 1.032
Moscow 943
Chandler 876
San Jose 697
Dallas 500
Jacksonville 464
Hong Kong 394
Dublin 341
Verona 298
Woodbridge 262
Beijing 251
Ann Arbor 235
The Dalles 225
New York 158
Wilmington 155
Lawrence 150
Princeton 150
Ho Chi Minh City 120
Los Angeles 116
Houston 104
Jinan 102
Redmond 80
Shenyang 80
Columbus 79
Council Bluffs 75
Hanoi 74
Nanjing 72
Sindelfingen 66
Tianjin 62
Redondo Beach 61
Buffalo 60
Hebei 59
Munich 58
Dong Ket 57
Santa Clara 57
São Paulo 57
Helsinki 55
Seattle 46
Orem 44
Tokyo 41
Changsha 40
Jakarta 37
Rome 37
Taizhou 37
Milan 36
Ningbo 35
Redwood City 35
Boardman 34
Brussels 33
Turku 33
Zhengzhou 32
Chicago 31
Haikou 30
Montreal 29
Jiaxing 27
Lancaster 27
Guangzhou 26
Kent 26
Nanchang 26
Vienna 26
San Francisco 25
Nuremberg 24
Phoenix 24
Hangzhou 23
Rio de Janeiro 23
Brooklyn 22
Seoul 22
Johannesburg 21
Taiyuan 21
Chennai 20
Frankfurt am Main 20
Atlanta 19
Warsaw 19
Amsterdam 17
Denver 17
London 17
Mianwali 17
Bologna 16
Norwalk 16
Baghdad 15
Da Nang 15
Lanzhou 15
Hyderabad 14
Porto Alegre 14
Shanghai 14
Brasília 13
Quito 13
Stockholm 13
Toronto 13
Abuja 12
Ankara 12
Bari 12
Barnet 12
Biên Hòa 12
Boston 12
Falkenstein 12
Fuzhou 12
Haiphong 12
Totale 12.519
Salva come PNG Salva come JPEG
Nome #
Common Variants Associated to Type 2 Diabetes in the Italian Population 491
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 256
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 252
LC3B and ph-S6K are both expressed in epithelioid and classic renal angiomyolipoma: a rationale tissue-based evidence for combining use of autophagic and mTOR targeted drugs 237
Terapia della glomerulonefrite membrano proliferativa. 204
IDENTIFICATION OF MOLECULAR BIOMARKERS FOR EARLY DIAGNOSIS OF DELAYED GRAFT FUNCTION IN RENAL TRANSPLANT RECIPIENTS 203
Abdominal-aortic atherosclerotic plaque index and perioperative outcomes in partial nephrectomy 202
Liver Metastases From Renal Oncocytoma With Vascular Extension 200
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FIG-2-induced renal epithelial-mesenchymal transition. 199
Identificazione del primo biomarcatore diagnostico urinario per il rene a spugna midollare (MSK): risultato di uno studio di proteomica mediante spettrometria di massa 199
A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients. 196
De Novo Renal Neoplasia After Kidney Transplantation According to New 2016 WHO Classification of Renal Tumors 195
Hairy cell leukemia in kidney transplantation: lesson from a rare disorder. 191
Histopathology and Long-Term Outcome of Kidneys Transplanted From Donors With Severe Acute Kidney Injury 187
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets. 185
mTOR inhibitors and renal allograft: Yin and Yang. 184
IDENTIFICAZIONE DI BIOMARCATORI MOLECOLARI PER LA DIAGNOSI PRECOCE DELLA FUNZIONALITÀ RITARDATA DELL'ORGANO TRAPIANTATO 182
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients. 180
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients. 180
The relationship between calcium kidney stones, arterial stiffness and bone density: unraveling the stone-bone-vessel liaison 178
Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy 178
Everolimus-associated interstitial pneumonia in a renal transplant patient: a case report 177
Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease. 177
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 177
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 176
Advantages of Using a Web-based Digital Platform for Kidney Preimplantation Biopsies 175
Extra-renal adverse effects of mTOR inhibitors: know them to optimize their use in renal transplantation. 175
ALTERED ANTIGEN HANDLING AND INVOLVEMENT OF THE CX3CR1-FKN AXIS IN PROMOTING HEMATURIA IN IGA NEPHROPATHY PATIENTS 172
Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitro. 171
Acute lymphoblastic leukemia with TEL-AML1 fusion has lower expression of genes involved in purine metabolism and lower de novo purine synthesis 171
Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects 170
Activated innate immunity and the involvement of CX3CR1-fractalkine in promoting hematuria in patients with IgA nephropathy 169
Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen. 168
Caratterizzazione del profilo trascrittomico nei linfomonociti periferici di trapiantati renali con rigetto cronico anticorpo-mediato (RCAM) 167
Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors. 167
Assessment of physical performance and body composition in male renal transplant patients 167
Monoclonal antibody therapy and renal transplantation: focus on adverse effects. 166
Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease 165
Donor-transmitted cancer in kidney transplant recipients: a systematic review 164
How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center 164
Altered modulation of WNT-beta-catenin and PI3K/Akt pathways in IgA nephropathy 163
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 161
Sulodexide and glycosaminoglycans in the progression of renal disease. 160
Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease. 159
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury. 159
The Genetic Architecture of Membranous Nephropathy and Its Potential to Improve Non-Invasive Diagnosis 158
How safe are organs from deceased donors with neoplasia? The results of the Italian Transplantation Network 157
In vitro effects of interleukin (IL)-1 beta inhibition on the epithelial-to-mesenchymal transition (EMT) of renal tubular and hepatic stellate cells. 157
Dialysis-related systemic microinflammation is associated with specific genomic patterns 157
Post-renal transplant pregnancy: a project to plan carefully 155
Mitochondria: a new therapeutic target in chronic kidney disease. 155
Sphingomyelin and medullary sponge kidney disease: a biological link identified by omics approach 154
Directional dominance on stature and cognition in diverse human populations. 153
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 152
Safety and Efficacy of Citrate Anticoagulation for Continuous Renal Replacement Therapy for Acute Kidney Injury After Liver Transplantation: A Single-Center Experience. 152
mTOR Inhibition Role in Cellular Mechanisms 152
Impact of renal replacement therapies on olfactory ability: results of a cross-sectional case control study 152
Genome analyses of >200,000 individuals identify 58 loci for chronic inflammation and highlight pathways that link inflammation and complex disorders 151
Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity. 150
Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in "Omics" Medicine. 150
A type I interferon signature characterizes chronic antibody-mediated rejection in kidney transplantation. 149
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients 148
Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation. 148
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 146
Mantenimento del trapianto renale: impatto clinico a lungo termine di tre diversi protocolli immunosoppressivi Risultati di un ampio studio multicentrico italiano 146
High-Dose Everolimus May Induce Pro-Inflammatory/Fibrotic Transcriptomic Changes in Bronchial Epithelial Cells from Cystic Fibrosis Patients 146
Sclerostin and Dickkopf-1 in post-menopausal renal allograft recipients. 144
Aberrantly Methylated DNA Regions Lead to Low Activation of CD4+ T Cells in IgA Nephropathy. 144
Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease. 144
Dialysis-related transcriptomic profiling: The pivotal role of heparanase. 143
New non-renal congenital disorders associated with medullary sponge kidney (MSK) support the pathogenic role of GDNF and point to the diagnosis of MSK in recurrent stone formers. 142
Tremor induced by Calcineurin inhibitor immunosuppression: a single-centre observational study in kidney transplanted patients 142
Karyopherins: potential biological elements involved in the delayed graft function in renal transplant recipients. 142
Nonalcoholic Fatty Liver Disease Increases Risk of Incident Chronic Kidney Disease: a Systematic Review and Meta-Analysis 142
Mortality from cancer is not increased in elderly kidney transplant recipients compared to the general population: a competing risk analysis 140
Alla ricerca di biomarker predittivi della ritardata ripresa funzionale del rene trapiantato: un utilizzo innovativo della genomica funzionale in trapiantologia. 139
Whole-genome sequencing coupled to imputation discovers genetic signals for anthropometric traits 139
Naturally Occurring Compounds: New Potential Weapons against Oxidative Stress in Chronic Kidney Disease. 139
From pharmacogenetics to pharmacogenomics: the birth of a new era of personalized medicine in nephrology 138
Late recovery of renal function in a patient with acute on chronic renal failure treated with peritoneal dialysis. 138
Glycosaminoglycans, proteoglycans and sulodexide and the endothelium: biological roles and pharmacological effects. 138
Involvement of heparanase in the pathogenesis of acute kidney injury: nephroprotective effect of PG545. 138
INCIDENCE OF PRIMARY GLOMERULONEPHRITIS IN A LARGE NORTH-EASTERN ITALIAN AREA: A 13-YEAR RENAL BIOPSY STUDY 136
Heparanase: another renal player controlled by vitamin d. 134
Analysis of urinary exosomes applications for rare kidney disorders. 134
Discovered cancers at postmortem donor examination: A starting point for quality improvement of donor assessment 134
Everolimus in kidney transplant recipients at high cardiovascular risk: a narrative review. 133
Impact of 3 Major Maintenance Immunosuppressive Protocols on Long-term Clinical Outcomes: Result of a Large Multicenter Italian Cohort Study Including 5635 Renal Transplant Recipients. 132
Copy Number Variant Analysis and Genome-wide Association Study Identify Loci with Large Effect for Vesicoureteral Reflux 132
In a retrospective international study, circulating miR-148b and let-7b were found to be serum markers for detecting primary IgA nephropathy. 131
Improved imputation of low-frequency and rare variants using the UK10K haplotype reference panel. 130
Gene expression and thioguanine nucleotide disposition in acute lymphoblastic leukemia after in vivo mercaptopurine treatment 128
Compiti e funzioni dei Centri Interregionali Trapianto 128
Proteomic Analysis of Urinary Extracellular Vesicles Reveals a Role for the Complement System in Medullary Sponge Kidney Disease 128
The UK10K project identifies rare variants in health and disease. 127
T helper 1, 2 and 17 cell subsets in renal transplant patients with delayed graft function. 126
Predictive model for delayed graft function based on easily available pre-renal transplant variables 126
Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury. 126
Pre-implantation kidney biopsy: value of the expertise in determining histological score and comparison with the whole organ on a series of discarded kidneys 126
The nephrologist of tomorrow: towards a kidney-omic future. 125
Totale 16.295
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.526
article - articoli 66.066
book - libri 0
conference - conferenze 4.037
curatela - curatele 0
other - altro 546
patent - brevetti 0
selected - selezionate 0
volume - volumi 877
Totale 143.052
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021339 0 0 0 0 0 0 0 0 0 25 112 202
2021/20221.044 77 173 16 194 29 32 35 77 45 26 91 249
2022/20232.536 174 342 230 450 200 564 31 142 275 12 87 29
2023/20241.431 60 100 101 118 145 188 33 366 6 69 189 56
2024/20253.090 166 225 122 558 158 96 131 172 465 181 274 542
2025/20268.506 653 450 546 1.444 2.237 674 810 501 654 537 0 0
Totale 21.439